. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cost-Benefit AnalysisEnglandFactor VIII/administration & dosageHemophilia A/economicsHemophilia A/therapyHome Care ServicesHumansNorwaySelf Administration
Substances: See more » Factor VIII
Year: 1979 PMID: 87970
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321